Matches in Nanopublications for { ?s ?p "[The effectiveness of the pro-drug FTY720 (known as fingolimod), approved for the treatment of multiple sclerosis, has become the gold standard for S1P-centric drugs, and will be used to illustrate the therapeutic value of modulating SphK1 and S1P receptor functions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP802616.RA950fVgRYQjugt6AENJHmM_tcg1rHz0_79Z_Kf4FYvi8130_assertion description "[The effectiveness of the pro-drug FTY720 (known as fingolimod), approved for the treatment of multiple sclerosis, has become the gold standard for S1P-centric drugs, and will be used to illustrate the therapeutic value of modulating SphK1 and S1P receptor functions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802616.RA950fVgRYQjugt6AENJHmM_tcg1rHz0_79Z_Kf4FYvi8130_provenance.
- NP1126503.RALsmwngbc0fyEwu9DAtxaOzlwVw4QTXpm5bflzIubMWU130_assertion description "[The effectiveness of the pro-drug FTY720 (known as fingolimod), approved for the treatment of multiple sclerosis, has become the gold standard for S1P-centric drugs, and will be used to illustrate the therapeutic value of modulating SphK1 and S1P receptor functions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126503.RALsmwngbc0fyEwu9DAtxaOzlwVw4QTXpm5bflzIubMWU130_provenance.